Last updated: August 1, 2024
Sponsor: Wake Forest University Health Sciences
Overall Status: Terminated
Phase
4
Condition
Skin Aging
Treatment
ReCell
Clinical Study ID
NCT05386368
IRB00085278
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adults 18 years or older
Patients undergoing facelift with perioral CO2 laser treatment
Skin that is Fitzpatrick Score 1 or 2
Exclusion
Exclusion Criteria:
Prior perioral CO2 laser resurfacing
Allergy to components of preparation system
Study Design
Total Participants: 1
Treatment Group(s): 1
Primary Treatment: ReCell
Phase: 4
Study Start date:
March 22, 2023
Estimated Completion Date:
May 06, 2024
Study Description
Connect with a study center
Wake Forest University Health Sciences
Winston-Salem, North Carolina 27157
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.